BillionToOne (BLLN) Non-Current Deffered Revenue (2025)

BillionToOne's (BLLN) quarterly Non-Current Deffered Revenue came in at $1.3 million in Q4 2025.

BillionToOne (BLLN) Non-Current Deffered Revenue (2025) Analysis & Trends

BillionToOne has disclosed Non-Current Deffered Revenue across 1 years of filings, most recently posting $1.3 million for Q4 2025.

  • Non-Current Deffered Revenue for Q4 2025 came in at $1.3 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $1.3 million (changed N/A YoY), and the FY2025 annual result was $1.3 million, changed N/A from the prior year.
  • Non-Current Deffered Revenue came in at $1.3 million for Q4 2025 at BillionToOne.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $1.3 million in Q4 2025 to a low of $1.3 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Waters 30,529.42 Bn 30,528.96 Bn 1.11 Bn -
2 Thermo Fisher Scientific 183.75 Bn 180.50 Bn 7.74 Bn -
3 Danaher 133.13 Bn 127.43 Bn 3.59 Bn -
4 Idexx Laboratories 46.14 Bn 45.94 Bn 722.74 Mn 32.31 Mn
5 Agilent Technologies 38.20 Bn 36.39 Bn 990.00 Mn -
6 Natera 31.50 Bn 30.40 Bn 696.04 Mn 17.00 Mn
7 Iqvia Holdings 31.34 Bn 29.36 Bn 1.36 Bn -
8 Illumina 24.51 Bn 23.36 Bn 721.00 Mn -
9 Mettler Toledo International 23.53 Bn 23.47 Bn 555.82 Mn -
10 BillionToOne 4.73 Bn 4.19 Bn 79.10 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 1.30 Mn